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Abstract: 
Extracts of the plant Echinacea purpurea are widely used for medicinal purposes. Effective 
quality control of these extracts requires rapid methods to determine their chemical composition. 
A new method for analysis of caffeic acid derivatives and alkamides from Echinacea extracts has 
been developed. With this method, isomeric isobutylamides and 2-methylbutylamides can be 
distinguished, a capability that previously published methods have lacked. Quantitative analyses 
carried out with this method on E. purpurea extracts that have been stored for 18 months indicate 
that they contain caftaric acid, cichoric acid, and undeca-2Z,4E-diene-8,10-diynoic acid 
isobutylamide at concentrations of 0.7, 0.71 and 2.0 mg/mL, respectively. 
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1. Introduction 
Preparations of the medicinal plant Echinacea purpurea are widely used for the treatment and 
prevention of upper respiratory infections [1]. It is estimated that approximately $300 million are 
spent on such preparations annually in the US alone [2]. Echinacea is believed to act by 
modulating the activity of the immune system. A number of constituent classes may be 
responsible for this immunomodulatory activity, including polysaccharides and glycoproteins, 
alkamides, and caffeic acid derivatives [3]. Recent studies also suggest that the compound 
melanin may contribute to the activity of Echinacea [4]. Of the compounds present in Echinacea, 
alkamides (also known as alkylamides) are of particular importance because they are the major 
constituents of the ethanol/water extracts of Echinacea that are widely used for therapeutic 
purposes. These constituents are also of interest because they are likely to cross the intestinal 
barrier [5], and because they are found in the bloodstream of patients who 
ingest Echinacea extracts [6]. Furthermore, recent studies suggest the involvement of alkamides 
in the in vitro [7] and in vivo [8] immunomodulatory activity of Echinacea extracts. Caffeic acid 
derivatives are also found in ethanol/water extracts of E. purpurea. These constituents are 
worthy of study because they are unique to particular species of Echinacea and can, therefore, be 
used for authentication and quality control of extracts and plant samples[9]. It has also been 
proposed that they play a role in the anti-inflammatory activity of Echinacea preparations[3]. 
A number of methods have previously been developed for the analysis of constituents from E. 
purpureaextracts. Typically, these techniques require two separate analyses for the determination 
of these two different constituents classes. For example, investigators have employed reversed 
phase HPLC coupled to UV spectrophotometric detection [10], coulometric electrochemical 
detection [11], or electrospray ionization mass spectrometric detection [12] for the determination of 
alkamides. Caffeic acid derivatives from E. purpurea extracts have been analyzed using reversed 
phase HPLC [13] or capillary electrophoresis [14] with photodiode array UV spectrophotometric 
detection. 
Recently, methods to determine both caffeic acid derivatives and alkamides in a single analysis 
have been developed. While it is more difficult to optimize the separation of such diverse 
constituents in one analysis, methods for the simultaneous determination of caffeic acid 
derivatives and alkamides are advantageous because they reduce both the time and sample size 
required for the analyses. The simultaneous analysis of caffeic acid derivatives and alkamides 
from E. purpurea has been accomplished using gradient elution reversed phase HPLC with 
photodiode array UV spectrophotometric detection [9] and [15] or electrospray ionization mass 
spectrometric detection [16]. Capillary electrophoresis using photodiode array UV 
spectrophotometric detection has also been employed for the simultaneous analysis of caffeic 
acid derivatives and alkamides from E. purpurea extracts [17]. To accomplish separation of these 
constituents with capillary electrophoresis, sodium dodecyl sulfate and hydroxypropyl-β-
cycoldetrin were used as additives, and a Britton–Robinson buffer (10 mM, pH 8.0) was 
employed [17]. 
Like some of the methods that have formerly been published, the method presented in this paper 
facilitates the determination of both caffeic acid derivatives and alkamides with a single reversed 
phase HPLC separation. This method is novel in several ways. First, a two-stage gradient elution 
is employed so that the caffeic acid derivatives elute during the first stage of the analysis, 
followed by the alkamides. The sequential elution of these two different constituent classes is 
advantageous because it allows the parameters of the mass spectrometer to be optimized for 
these structurally diverse compounds during the time period in which they elute. The previously 
published HPLC/electrospray ionization mass spectrometry method for simultaneous analysis of 
caffeic acid derivatives and alkamides required switching between positive and negative cone 
voltages throughout the analysis [16], which can lead to losses in stability and sensitivity. A 
second novel aspect of the method presented here is that identifications of constituents made on 
the basis of retention time and mass-to-charge ratio (m/z) of the molecular ion are confirmed 
using MS–MS fragmentation patterns. This is possible because the mass spectrometer used in the 
work described here employs an ion trap mass analyzer, which provides the capability to 
generate fragmentation patterns of selected precursor ions by collisionally induced dissociation. 
Previous studies used a mass spectrometer with a single quadrupole mass analyzer [12] and [16], 
which does not provide MS–MS spectra. The structures and masses of characteristic caffeic acid 
derivative and alkamide MS–MS fragments can be used for structural elucidation of constituents 
from unknown samples, and provide more conclusive structural information than was possible 
with previously published HPLC/ESI-MS methods [12] and [16]. 
2. Experimental 
2.1. Preparation and storage of extracts 
Ethanol/water extracts of fresh E. purpurea roots were obtained from Horizon Herbs (Williams, 
OR). These extracts were prepared at the Horizon Herbs facility as follows. Fresh dormant roots 
of authentic E. purpureaplants (cultivated on the Horizon Herbs farm) were washed thoroughly 
and weighed to the nearest 1 g. A 1:2 extract (1 g of plant material: 2 mL solvent) was prepared 
with a final ethanol content of 50% (accounting for water from the plant material as well as the 
solvent). The solvent used for the extraction consisted of 75% grain alcohol (190 proof or 95% 
pharmaceutical grade ethanol) and 25% filtered water. The plant material and solvent were 
thoroughly blended using a commercial grade blender and allowed to macerate for a period of 14 
days. The extract was then expressed from the plant material using a hydraulic press and filtered. 
Small aliquots of this extract were sent to the analytical laboratory at the University of North 
Carolina Greensboro for analysis. Two batches of extracts, one prepared in the fall of 2002 and 
one in the fall of 2003, were analyzed. Prior to analysis, the extracts were stored under ambient 
light in amber bottles with screw caps at room temperature (approximately 22 °C). These storage 
conditions were chosen to match as closely as possible those used for storage of extracts that are 
used for medicinal purposes. At the time of analysis, one extract had been stored for 6 months 
and the other for 18 months. 
2.2. Analysis of extracts with HPLC and ESI-MS 
An aliquot (1 mL) of each extract was centrifuged to pellet particulate matter and the supernatant 
was filtered with a 0.2 μm filter prior to analysis. The extract was then diluted 10-fold in a 
solvent of 50% ethanol (95% HPLC grade ethanol from Fisher Scientific) and 50% nanopure 
water (filtered with a nanodiamond water purification system from Barnstead, Dubuque, IA, 
USA). The content of this dilution solvent was chosen to match that of the extract to minimize 
precipitation. 
The analysis was carried out with reversed phase HPLC coupled to electrospray ionization mass 
spectrometry (ESI-MS). The HPLC system used for the separation was an HP1100 (Agilent, 
Palo Alto, CA, USA) with a short, narrow bore C18 column (50 mm × 2.1 mm, 3 μm particle 
size, 110 Å pore size, Prevail packing, Alltech, Deerfield, IL, USA). A 0.5 μm precolumn filter 
(MacMod Analytical, Chadds Ford, PA, USA) was attached to the column inlet to remove any 
particulate caused by precipitation of the samples in the HPLC solvents. All samples were run in 
triplicate with an injection volume of 5 μL. The flow rate was set to 0.2 mL/min and the gradient 
used was as follows (where A = 1% acetic acid in nanopure water and B = HPLC grade 
acetonitrile): t = 0–4 min, 90% A (10% B); t = 4–15 min, 90–60% A (10–40% B); t = 15–
30 min, 60–40% A (40–60% B); t = 30.1–35 min, 0% A (100% B); t = 35.1–43 min, 90% A 
(10% B). 
The outlet of the HPLC column was directly connected to the electrospray ionization source of 
an ion trap mass spectrometer (LCQ Advantage, Thermofinnigan, San Jose, CA, USA). The 
mass spectrometer was operated with a scan range of 150–1000 m/z, a capillary temperature of 
275 °C, a sheath gas pressure of 40 arb, and spray, capillary, and tube lens voltages of 4.5 kV, 
10 V and 50 V, respectively. It was tuned in the positive ion mode using a solution of caffeine 
(m/z 195). The mass spectrometer was operated in the negative ion mode the first 15 min of the 
analysis, then switched to the positive ion mode for the remainder. The total analysis time was 
43 min. 
MS–MS analyses were accomplished using the data dependent acquisition capabilities of the 
Xcalibur data system (Thermo Finnigan, San Jose, CA, USA, version 1.2). With this method of 
MS–MS, the scan mode alternates between full scan MS and MS–MS of the most intense peak 
from the full scan mass spectrum. In this way, both MS and MS–MS spectra are obtained for 
each major component of the extract as it elutes from the column. The instrument was again 
operated in the negative ion mode for the first 15 min of the analysis and then switched to 
positive ion mode. The collision energy was set at 35%. 
2.3. Isolation of an alkamide standard 
The standard to be used for quantification of alkamides was isolated from a 100% 
ethanol Echinacea extract using HPLC with fraction collection. An HPLC (Shimadzu, USA, 
LC10AT vp) with a UV photodiode array detector and a Haisil 100 C18 column 
(150 mm × 100 mm, 5 μm particle size, 100 Å pore size, Higgins Analytical, Mountain View, 
CA, USA) was used. The injection volume for this analysis was 250 μL and the flow rate was 
1.5 mL/min. The separation was accomplished isocratically with a solvent composition of 50% 
A, 50% B (where A = 1% trifluoroacetic acid in water and B = 1% trifluoroacetic acid in 
acetonitrile). The peak that eluted from the column at 16.5 min was collected and analyzed using 
the same HPLC/ESI-MS method described for analysis of alkamides above. One major peak was 
observed in the chromatogram resulting from the HPLC/ESI-MS analysis of the standard 
compound with a molecular ion at a m/z value of 230.2. This peak was identified on the basis of 
previous literature [3] and [12] as undeca-2Z,4E-diene-8,10-diyonic acid isobutylamide (alkamide 4 
in Fig. 1). The collected fractions from several separations were combined in a preweighed 
centrifuge tube and the solvent was removed under vacuum to determine dry weight. They were 
then redissolved in ethanol at a concentration of 1 mg/mL (4.3 × 10−3 M). 
 
Fig. 1. Structures of selected caffeic acid derivatives and alkamides present in Echinacea 
purpurea extracts. A more comprehensive list of compounds identified can be found in Table 1. 
2.4. Preparation and analysis of standards 
Standards for the caffeic acid derivative compounds caftaric acid, chlorogenic acid, and cichoric 
acid (see structures in Fig. 1), all of which are found in E. purpurea, were purchased from 
Chromadex (Santa Ana, CA, USA). Stock solutions of caftaric acid and chlorogenic acid were 
prepared at concentrations of 1 × 10−2 M in ethanol. A stock solution of cichoric acid, which has 
poor solubility in neat methanol, was prepared at a concentration of 5 × 10−3 M in 50% ethanol 
(reagent grade alcohol, Fisher Scientific, USA) and 50% nanopure water. Using these stock 
solutions and the stock solution of the alkamide undeca-2Z,4E-diene-8,10-diyonic acid 
isobutylamide (isolated from E. purpurea as described in Section 3.3), an equimolar mixture of 
standards was prepared at a concentration of 5 × 10−4 M. This stock solution was stored in a 
polypropylene centrifuge tube at −20 °C until time of use, when it was serially diluted to make 
five standard mixtures at concentrations of 2 × 10−4 M, 1 × 10−4 M, 5 × 10−5 M, 2 × 10−5 M and 
1 × 10−5 M. 
The five calibration solution mixtures were analyzed using the methods described for analysis of 
extracts in Section 3.2. The standards were analyzed on the same day as the extracts to minimize 
errors that might be introduced due to day-to-day variability in instrumental response. Using the 
data obtained from these analyses, calibration curves were prepared for caftaric acid 
(compound 1, Fig. 1), cichoric acid (compound 2, Fig. 1), and undeca-2Z,4E-diene-8,10-diynoic 
acid isobutylamide (compound 4, Fig. 1). These curves were plotted as peak area of the selected 
ion chromatogram for the ion of interest versus concentration. 
A stock solution of standard dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide (Chromadex, 
Santa Ana, CA, USA) was also prepared at a concentration of 2.0 × 10−4 M in ethanol. This 
solution was stored at +4 °C in a polypropylene centrifuge tube, then diluted to a concentration 
of 1.0 × 10−5 M prior to analysis. Although this compound was not included in the mixture used 
for quantification, it was used for identification of one of the alkamides in the extract as 
discussed later. 
3. Results and discussion 
3.1. Identification of constituents of E. purpurea extracts 
Two different caffeic acid derivatives and 11 different alkamides were identified in the E. 
purpurea extracts. It is relevant to note all of these compounds were identified in both extracts, 
even though at the time of analysis, one extract was an entire year older than the other. Structures 
of the caffeic acid derivatives identified and of several representative alkamides are shown 
in Fig. 1. A more comprehensive identification is provided in Table 1, along with the masses of 
ions observed with ESI-MS and MS–MS. Standards were available for caftaric acid 
(compound 1), cichoric acid (compound 2) and dodeca-2E,4E,8Z,10E-tetraenoic acid 
isobutylamide (compound 11), therefore, the identities of the peaks representing these 
compounds in Fig. 2 were confirmed by matching the MS–MS fragmentation patterns and 
retention times of the compounds in the extract with those of the standards. Both the masses and 
the relative intensities for fragments of these standards were identical to those obtained for the 
compounds from the extracts (see Table 1). For the 10 alkamides for which standards were not 
available, the identities of the compounds were assigned by comparison of retention time order 
and molecular weight of constituents in the E. purpurea extracts with previously published 
literature [12], [16], [18] and [19], and by interpretation of MS–MS spectra, as discussed later on. 
Table 1. Assignment of identities of constituents of E. purpurea extracts 
Number Compound Precursor ion 
(m/z) 
Product ions (m/z) 
1 Caftaric acid 311.1 
(M − H−) 
149, 179, 135 
2 Cichoric acid 473.1 
(M − H−) 
311, 293, 149, 179, 341 
3 Undeca-2E,4Z-diene-8,10-diynoic acid 
isobutylamide 
230.1 
(M + H+) 
131, 129, 174a, 91, 157b 
4 Undeca-2Z,4E-diene-8,10-diynoic acid 
isobutylamide 
230.1 
(M + H+) 
131, 174a, 129, 146, 
157b 
5 Dodeca-2Z,4E-diene-8,10-diynoic acid 
isobutylamide 
244.1 
(M + H+) 
145, 188a, 117, 143, 
171b 
6 Dodeca-2E,4Z,10E-triene-8-ynoic acid 
isobutylamide 
246.1 
(M + H+) 
147, 145, 173b, 131, 
119, 105, 190a 
7 Undeca-2E,4Z-diene-8,10-diynoic acid 2-
methylbutylamide 
244.1 
(M + H+) 
131, 174c 145, 129, 117, 
157d 
8 Dodeca-2Z,4E-diene-8,10-diynoic acid 
isobutylamide 
244.1 
(M + H+) 
145, 117, 171b, 143, 
188a 
9 Dodeca-2,4-diene-8,10-diynoic acid 2-
methylbutylamide 
258.1 
(M + H+) 
145, 117, 188c 147, 
171d 
10 Dodeca-2E,4Z-diene-8,10-diynoic acid 2-
methylbutylamide 
258.1 
(M + H+) 
145, 117, 171d,143, 
188c, 128, 202 
11 Dodeca-2E,4E,8Z,10E/Z-tetraenoic acid 
isobutylamide 
248.2 
(M + H+) 
149, 142, 147, 175b, 
107, 192a 
12 N.I. 248.2 
(M + H+) 
166, 149, 167, 107, 175, 
93, 121 
13 N.I. 262.2 149, 156, 147, 175, 133 
(M + H+) 
14 Dodeca-2E,4E,8Z-trienoic acid 
isobutylamide 
250.2 
(M + H+) 
167, 177b, 95, 149, 109, 
177, 194a 
15 Dodeca-2E,4E-dienoic acid isobutylamide 252.1 
(M + H+) 
179b, 196a, 161, 95, 119 
Fragments are shown in order of relative intensity in MS–MS spectra. Compounds in italics have 
been assigned different structures than in previous literature on the basis of MS–MS spectra. E/Z 
stereochemistry is indicated here in accordance with existing literature [12], [16], [18] and [19], but it 
should be acknowledged that without conformational NMR spectra, it is not possible to 
conclusively distinguish between E and Z isomers. a Fragment formed by dissociation of the C–N 
bond of an isobutylamide to lose the alkyl group directly attached to the amine (MH+ − 56). b 
Fragment formed by dissociation of the C–N bond of an isobutylamide to lose the entire amine 
functional group (MH+ − 73). c Fragment formed by dissociation of the C–N bond of a 2-
methylbutlyamide to lose the alkyl group directly attached to the amine (MH+ − 70). d Fragment 
formed by dissociation of the C–N bond of a 2-methylbutylamide to lose the entire amine 
functional group (MH+ − 87). 
 
Fig. 2.  (a) A typical base peak chromatogram obtained using the method presented in this paper. 
The mass of the base peak in the mass spectrum is labeled above the major peaks in the 
chromatogram. The peak numbers correspond to the compounds in Table 1. The signal during 
the first 15 min represents the intensity of negative ions striking the detector in the mass 
spectrometer, while the signal between 15 and 43 min represents the intensity of positive ions 
striking the detector. (b) Selected ion chromatograms for some of the minor constituents of 
the Echinacea purpurea extracts. These ions are shown with selected ion chromatograms 
because their signals are either too weak to be distinguished in the total ion chromatogram 
(compound 1) or because they co-elute with other constituents in the Echinacea purpurea extract 
(compound 6). 
Fig. 2 shows a typical base peak chromatogram obtained from an E. purpurea extract analyzed 
using the method presented here. Peaks 1 and 2 represent caffeic acid derivatives, which elute 
first in the reversed phase HPLC separation because they are more polar than the alkamides. The 
remaining peaks represent various alkamides. The mass spectrometer is set in negative ion mode 
for the first stage of the analysis (0–15 min), during which time the caffeic acid derivatives elute 
from the column. These compounds are detected in the negative ion mode as the deprotonated 
molecular ion due to their acidic functionality (see Fig. 1). For the second stage of the analysis 
(15–43 min), the mass spectrometer is operated in the positive ion mode to facilitate detection of 
the alkamides. These compounds are slightly basic, and are detected in the positive ion mode as 
protonated molecular ions. 
3.2. Mass spectra for the identification of caffeic acid derivatives 
Three caffeic acid derivatives are commonly found in E. purpurea, caftaric acid, chlorogenic 
acid, and cichoric acid [3]. Of these, caftaric acid and cichoric acid were identified in the E. 
purpurea extracts studied here. The detection limit for standard chlorogenic acid with this 
method was approximately 1 × 10−4 M (35 μg/mL). Thus, it can be concluded that chlorogenic 
acid was not present in the extracts at a concentration above approximately 35 μg/mL. 
The electrospray ionization mass spectrum of a typical caffeic acid derivative consists of two 
peaks, one for the deprotonated molecular ion and another for a proton bound dimer of this 
compound. For example, Fig. 3a is a mass spectrum corresponding to chromatographic peak (1) 
in Fig. 2. There are two major ions present in this mass spectrum, one at m/z 311.2, which 
corresponds to deprotonated caftaric acid (see proposed structure, Fig. 3a) and another 
at m/z 623.1, which corresponds to a proton bound dimer of caftaric acid (a cluster consisting of 
one neutral caftaric acid molecule bound to one deprotonated caftaric acid molecule). 
 
Fig. 3.  (a) A mass spectrum of a standard solution of caftaric acid (Chromadex, Santa Ana, CA). 
This spectrum was obtained using the HPLC method as described in Section 2, using a 5 μL 
injection of a solution of 1.0 × 10−5 M caftaric acid in ethanol. The mass spectrum consists of 
two peaks, the first representing deprotonated caftaric acid (M − H− at m/z 311.1), and the second 
a proton bound dimer of two caftaric acid molecules (2M − H− at m/z 623.1). (b) The MS–MS 
spectrum obtained by fragmentation of the ion in spectrum (a) with m/z of 311.1. This spectrum 
consists of two major peaks, the tentative structures of which are assigned in the figure. 
Structural interpretation was accomplished using Mass Frontier Software (Thermo Finnigan, San 
Jose, CA). The structures of the fragments correspond to the expected results of fragmentation of 
the weakest bonds in the molecule with collisionally induced dissociation (CID). 
The MS–MS fragmentation spectrum obtained from the M − H− ion of caftaric at m/z 311.2 is 
shown in Fig. 3b. The fragments in Fig. 3b are produced by collisionally induced dissociation 
within the ion trap mass analyzer of the mass spectrometer. Proposed structures of the caftaric 
acid fragments are shown in Fig. 3b. These structures were assigned with the help of the Mass 
Frontier Software (Thermo Finnigan, San Jose, CA). The MS–MS spectra for caftaric acid and 
cichoric acid from the E. purpurea extract (peaks 1 and 2, Fig. 2) matched the MS–MS spectra 
obtained from standards of these compounds in terms of both relative intensities and m/z values 
of fragment ions. See Table 1 for a complete list of the major fragments produced by 
collisionally induced dissociation of caftaric acid and cichoric acid. 
3.3. Mass spectra for the identification of alkamides 
Alkamides also produce characteristic mass spectra, as shown in Fig. 4a, which displays the 
mass spectrum corresponding to peak 11 in Fig. 2. The major ions observed in this mass 
spectrum correspond to protonated dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamide (the 
structure of the Z isomer is shown) and its proton bound dimer (a cluster of two neutral dodeca-
2E,4E,8Z,10E/Z-tetraenoic acid isobutylamide molecules sharing a single proton). It has 
previously been reported that it is difficult to separate the E and Z isomers of dodeca-
2E,4E,8Z,10E/Z-tetranoic acid isobutlyamide [12]; thus, it is possible that peak 11 in Fig. 
2 represents a mixture of these isomers, and it is not possible to say which isomer is represented 
in the mass spectrum in Fig. 4a. Standard dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide 
(Chromadex, Santa Ana, CA, USA) was analyzed, and its mass spectrum, MS–MS spectrum, 
and retention time matched that of peak 11 in Fig. 2. 
 
Fig. 4.  (a) The mass spectrum of peak 11 in Fig. 2 analyzed with the HPLC/ESI-MS method 
described in Section 2. The peaks in the spectrum correspond to the protonated form of the 
compound (M + H+) at m/z 248.1 and a proton bound dimer (2M + H+) at m/z495.9. 
The m/z values of the protonated molecular ion and the dimer match exactly with those obtained 
from analysis of a standard of dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide (Chromadex). 
(b) An MS–MS spectrum obtained from the precursor ion with m/z 248.2 from an Echinacea 
purpurea extract, the mass spectrum of which is shown in part (a). Both the m/z values and 
relative intensities of these fragments match exactly with those obtained by fragmenting the 
protonated molecular ion of standard dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide 
at m/z 248.2. The tentative structures of the fragments were generated using Mass Frontier 
Software based on the proposed structure of the parent compound. Major fragments are observed 
due to dissociation of the C–N bonds corresponding to loss of the isobutyl group attached to the 
nitrogen and loss of the entire amine functionality (see structures in the figure). 
The MS–MS fragmentation spectrum produced upon collisionally induced dissociation of the ion 
with m/z248 is shown in Fig. 4b. Major sites of fragmentation are the CN bonds of the amide 
functional group. Fragments corresponding to loss of the alkyl group attached to the nitrogen 
(m/z 192 in Fig. 4b) and loss of the entire amine portion of the molecule (m/z 175 in Fig. 4b) are 
observed. The structures of these fragments are shown in the figure. 
The fragments that result from dissociation of the CN bonds can be expected for any alkamide, 
and can be used in conjunction with retention order and m/z of the protonated molecular ion to 
obtain structural information. There are two types of alkamides that have been identified 
in Echinacea, isobutylamides, in which an isobutyl group is attached to the amide nitrogen (for 
example, compounds 3, 4 and 11 in Fig. 1), and 2-methylbutylamides, in which a 2-methylbutyl 
group is present in place of the isobutyl group (for example, compound 7 in Fig. 1). In many 
cases, both the isobutyl and 2-methylbutyl amide isomers of a given alkamide are present in the 
extract. By definition, these isomers have the same mass and cannot be distinguished on the basis 
of molecular weight of the protonated molecular ion. Therefore, MS–MS spectra are invaluable 
for distinguishing between them. 
MS–MS spectra can be used to distinguish isobutylamides and 2-methylbutlyamides. For any 
isobutylamide, fragments should be observed in the MS–MS spectrum corresponding to a loss of 
56 (for the isobutyl group) and a loss of 73 (for the isobutyl amine). Examples of MS–MS 
spectra that include the characteristic −56 and −73 fragments are displayed in Figs. 4b and 5a, 
which represent fragmentation of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamide and 
dodeca-2,4-diene-8,10-diynoic acid isobutylamide, respectively. For 2-methylbutylamides, 
fragments corresponding to a loss of 70 (for the 2-methylbutyl group) and a loss of 87 (for the 2-
methylbutyl amine) will be observed. An example 2-methylbutylamide MS–MS spectrum that 
displays these fragments is shown in Fig. 5b. 
 
Fig. 5. (a) MS–MS spectrum obtained from the MH+ ion at m/z 244 (peak 5 in Fig. 2). This 
spectrum represents fragmentation of dodeca 2Z,4E-diene-8,10-diynoic acid isobutylamide. 
Fragments that aid particularly in its identification are the MH+ − 56 ion at m/z 188 and the 
MH+ − 73 ion at m/z 171. With the MS–MS spectrum, this compound can easily be distinguished 
from the 2-methylbutylamide from Echinacea purpurea with the same parent mass (Fig. 5b). (b) 
MS–MS spectrum obtained from the M + H+ion at m/z 244 (peak 7 in Fig. 2). This compound 
can be identified as undeca-2E,4Z-diene-8,10-diynoic acid 2-methylbutylamide. The ions that 
are particularly helpful in this identification are the MH+ − 70 ion at m/z 174 and the MH+ − 87 
ion at m/z 157. 
It is important to note that the fragments produced by dissociation of the CN bonds are not the 
only fragments observed in MS–MS spectra of alkamides from Echinacea. Quite on the contrary, 
these compounds produce complex MS–MS spectra ( Fig. 4 and Fig. 5) with many peaks that 
likely arise due to fragmentation of the main carbon chain. The main carbon chains of alkamides 
have many sites of unsaturation ( Fig. 1) and, consequently, would be expected to produce 
multiple stable cations upon collisionally induced dissociation. The structures of some of these 
cations are shown in Fig. 4 and Fig. 5. 
The MS–MS spectra generated with the method described herein can be used to correctly 
identify compounds that have been misidentified in other studies. For example, peak 5 in Fig. 2, 
which corresponds to an ion with m/z 244, has been assigned to undeca-2E,4Z-diene-8,10-
diynoic acid 2-methylbutylamide in published work [12] and [16]. However, its MS–MS fragments 
( Fig. 5a) suggest that the true identity of this compound is dodeca-2Z,4E-diene-8,10-diynoic 
acid isobutylamide, the most recent isobutylamide to be discovered in E. purpurea extracts [19]. 
Fragments of this compound are observed at m/z 171, representing loss of an isobutyl group, and 
188, representing the loss of the isobutylamine. The fragments that would be expected if this 
compound were a 2-methylbutylamide are absent from its MS–MS spectrum. The MS–MS 
spectrum for peak 7 in Fig. 2 ( Fig. 5b) does demonstrate the expected fragments for undeca-
2E,4Z-diene-8,10-diynoic acid 2-methylbutylamide. Peaks at m/z 174 (for loss of the 2-
methylbutyl group) and 157 (for loss of the entire amine) are observed. Thus, on the basis of 
MS–MS spectra, peak 7 is assigned to undeca-2E,4Z-diene-8,10-diynoic acid 2-
methylbutylamide and peak 5 is assigned to dodeca-2Z,4E-diene-8,10-diynoic acid 
isobutylamide ( Table 1). 
Another example of the usefulness of MS–MS spectra for the purposes of identity confirmation 
is provided for the case of compound 9 (Table 1). In a recent publication [16], this compound was 
identified as trideca-2E,7Z-diene-10,12-diynoic acid isobutylamide. The fragments observed in 
the MS–MS spectra (Table 1), however, clearly show that this compound is a 2-
methylbutylamide and not an isobutylamide. Fragments are observed at m/z 188 (−70, loss of a 
2-methybutly group) and m/z 171 (−87, loss of 2-methylbutylamine). For this reason, the 
compound has been tentatively identified here as an isomer of compound 10, dodeca-2,4-diene-
8,10-diynoic acid 2-methylbutylamide. 
3.4. Quantification of constituents of E. purpurea extracts 
Calibration curves were prepared for caftaric acid, cichoric acid (from Chromadex) and undeca-
2Z,4E- (isolated from an E. purpurea extract). These calibration curves were plotted as area of 
the selected ion chromatogram for the protonated molecular ion of the compound of interest 
versus concentration. The linear regression equations and statistical data for the three calibration 
curves are reported in Table 2. The calibration curves were linear over a range of approximately 
2 × 10−5 to 5 × 10−4 M. Above this concentration, loss of linearity was observed. 
Table 2. Calibration curve data for standard caffeic acid derivative and alkamides 
Compound Slope (±standard 
deviation) 
Intercept (±standard 
deviation) 
Standard 
error 
Concentration 
range (M) 
Caftaric acid (1) 1.43 × 1011(±8 × 109) −2.9 × 106 (±2 × 106) 3.2 × 106 2 × 10−5 to 
5 × 10−4 
Cichoric acid (2) 1.69 × 1012(±2 × 1010) −1.5 × 107 (±2 × 106) 3.3 × 106 1 × 10−5 to 
2 × 10−4 
Undeca-2Z,4E-
diene-8,10-
diynoic acid 
isobutylamide (4) 
7.35 × 1011(±3 × 1010) 6.0 × 106 (±3 × 106) 4.0 × 106 1 × 10−5 to 
2 × 10−4 
Calibration curves were plotted as peak area of the selected in chromatogram for the ion of 
interest vs. concentration (M). Each calibration curve included five data points (n = 5). 
Instrumental factors such as overfilling of the ion trap mass analyzer or saturation in the 
ionization process are likely to be major contributors to the loss of linearity observed in 
calibration curves at high concentrations. Another factor in this loss of linearity is the formation 
of dimer ions. As shown in Fig. 3 and Fig. 4, dimer ions are commonly observed in the 
electrospray ionization mass spectra of both caffeic acid derivatives and alkamides. The relative 
intensities of the ions representing the monomer and dimer vary depending on the concentration 
of the solution. The dimer ion may be completely absent in very dilute solutions, but its intensity 
increases dramatically as the solution concentration is increased. Even if the signal for the dimer 
ion is included in the overall peak area, discrimination by the mass analyzer or differences in 
ionization efficiency of the monomer versus the dimer could contribute to a loss of linearity at 
high concentrations where dimer formation is significant. For this reason, it is advisable to dilute 
extracts prior to analysis such that the concentrations of the compounds of interest fall within the 
linear range of the calibration curve. Of course, attention must be paid that dilution does not 
cause minor constituents to become too dilute to be detected. In this study, extracts were diluted 
10-fold prior to analysis to achieve responses within the linear dynamic range of the calibration 
curves. 
Quantitative analysis was performed on two different Echinacea extracts that had been stored for 
various lengths of time. The two extract batches were both prepared using the same method, as 
described in Section 2.1, but extract 1 was prepared in 2002 and extract 2 was prepared in 2003, 
and they were prepared using different batches of Echinacea roots. At the time of analysis, 
extract 1 had been stored for 12 months and extract 2 had been stored for 6 months (see 
Section 2.1 for storage conditions and details on methods of analysis). 
The results of the quantitative analyses of the extracts are shown in Table 3. As mentioned in the 
previous section, all of the same alkamides and caffeic acid derivatives listed in Table 1 were 
identified in both of the extracts. Quantitative data is, however, only provided for the two caffeic 
acid derivatives and one alkamide for which standards were available at the time of analysis. 
Because extracts 1 and 2 were prepared from different plant samples in different years, one 
would expect to observe some difference in the concentrations of active constituents. This 
variation in concentration could result from a number of variables besides extract age, including 
differences in plant water content or in concentration of constituents among different genotypes 
or phenotypes of E. purpurea plants used to prepare the extracts. Given all of these variables, it 
is remarkable that the profile of constituent concentrations in the two extracts (column 2 versus 
column 3 in Table 3) is quite similar. It can be concluded from these data that significant 
concentrations of alkamides and caffeic acid derivatives are present in ethanol/water extracts 
of E. purpurea even after storage for periods of longer than 1 year. However, these data do not 
rule out the possibility that these constituents degrade somewhat over time. The extent to which 
degradation of caffeic acid derivatives and alkamides occur in E. purpurea extracts could be the 
subject of future studies. Because extracts of E. purpurea that are used for medicinal purposes 
are commonly stored at room temperature in glass bottles for some time prior to use by the 
consumer, such studies would seem quite relevant. 
Table 3. Quantities of alkamides and caffeic acid derivatives in E. purpurea extracts 
Compound Extract #1 (stored for 18 months) Extract #2 (stored for 6 months) 
 Concentration 
(±sx) (mg/mL) 
Concentration (±sx) 
(M) 
Concentration 
(±sx) (mg/mL) 
Concentration (±sx) 
(M) 
Caftaric 
acid (1) 
0.7 (±0.2) 2.4 × 10−3(±8 × 10−4) 0.52 (±0.07) 1.7 × 10−3(±2 × 10−4) 
Cichoric 
acid (2) 
0.71 (±0.09) 1.5 × 10−3(±2 × 10−4) 0.54 (±0.05) 1.1 × 10−3(±1 × 10−4) 
Undeca-2Z,4E-
diene-8,10-
diynoic acid 
isobutylamide 
(4) 
2.0 (±0.07) 8.7 × 10−3(±3 × 10−4) 1.60 (± 0.05) 7.0 × 10−3(±2 × 10−4) 
Quantitative analysis was accomplished using the calibration curve data from Table 2. The 
extracts were diluted 10-fold prior to analysis to adjust the concentrations to within the 
calibration curve concentration ranges. Standard deviations are for three replicate analyses. 
4. Conclusion 
In this paper, a novel HPLC/ESI-MS–MS method is presented for the quantitative and qualitative 
analysis ofE. purpurea extracts. This method is an improvement on existing methods because 
MS–MS fragmentation patterns of alkamides and caffeic acid derivatives are taken into 
consideration when making identifications. Because E. purpurea extracts contain many isomeric 
alkamides, the additional level of certainty in structural elucidation provided by the use of MS–
MS spectra is invaluable. Previous methods of identification that relied solely on the retention 
time and m/z value of the protonated molecular ion were more prone to misidentification than is 
the method presented here. 
The results obtained from these studies should be useful to researchers studying the chemical 
composition and biological activity of E. purpurea extracts in several ways. First, new data is 
provided about the structure of alkamides present in these extracts, and several previously 
published misidentifications are corrected. Second, the quantitative analyses of E. 
purpurea extracts of various ages published here indicate that alkamides and caffeic acids are 
still present at significant concentrations in ethanol/water extracts of this plant stored for longer 
than one year. These findings are important because alkamides and caffeic acid derivatives have 
been identified as possible active constituents of E. purpurea. However, more in-depth studies 
about stability of alkamides in extracts of E. purpurea are warranted. Ideally, these studies would 
employ a method validated for quantification of the constituents from E. purpurea extracts to 
analyze a single extract at the time it was prepared and then after storage for under a variety of 
conditions for various lengths of time. 
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